Pharmaceuticals

Cell Regeneration Medicine Market Revenue Outlook: Strategic Insights and Forecast to 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Cell Regeneration Medicine Market From 2025 to 2029?#_x000D_

In recent years, the budesonide market has demonstrated robust growth. The market, which was worth $9.72 billion in 2024, is projected to escalate to $10.26 billion in 2025, displaying a compound annual growth rate (CAGR) of 5.6%. Various factors have propelled this growth during the historic period, which include the proliferating incidence of respiratory diseases, enhanced consciousness regarding inhaled corticosteroids and the roll-out of combination therapies involving budesonide. Additionally, the growth of healthcare facilities and increased access to them and the off-label utilization of budesonide in treating inflammatory bowel diseases have also contributed to this increase._x000D_

_x000D_

In the upcoming years, the budesonide market is anticipated to witness robust expansion, proliferating to “$12.95 billion by 2029 at a CAGR of 6.0%. The expansion during the forecast period is owing to factors such as the increased need for potent treatments, the evolution of innovative drug delivery methods, heightened usage of budesonide, a growing elderly population susceptible to asthma, and the proliferation of generic budesonide products. Major forecasts for the period include the embracement of biologics and biosimilars, improvement in drug delivery systems, regulatory endorsements for new formulations, the evolution of innovative drug delivery platforms, and technological progress._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Cell Regeneration Medicine Market?#_x000D_

The cell regeneration medicine market is forecasted to grow, spurred by the increasing acceptance of organ transplantation. This medical procedure involves transferring an organ from one body to another, substituting a damaged or lost organ. Its popularity has surged due to the extended lifespan it offers and the sidestepping of medical processes like dialysis. Cell regeneration medicine significantly upgrades organ transplantation by concentrating on the repair and regeneration of impaired tissues or organs. In January 2023, the United Network for Organ Sharing, a scientific and educational association based in the US, reported that approximately 42,887 organ transplants performed in the US in 2022, marking a 3.7% rise from 2021. Consequently, the escalating acceptance of organ transplants will stimulate the cell regeneration medicine market._x000D_

_x000D_

The budesonide market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI) _x000D_

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers _x000D_

3) By Injectable Suspension: Pre-filled Syringes, Vials _x000D_

4) By Tablets And Capsules: Oral Tablets, Oral Capsules_x000D_

_x000D_

#What Are The Leading Trends And Opportunities In The Cell Regeneration Medicine Sector?#_x000D_

Leading firms in the budesonide market are prioritizing innovations in respiratory treatments like oral therapy, aiming to increase patient comfort, enhance adherence to therapy, and broaden the range of therapeutic solutions for managing asthma and other respiratory problems. The oral budesonide therapy is a formulation consumed orally, mainly for treating inflammatory conditions. In February 2024, for example, Takeda Pharmaceuticals, a pharmaceutical company from Japan, revealed that the US’ Food and Drug Administration (FDA) had given approval to EOHILIA, a budesonide oral suspension, making it the first and sole FDA-approved oral drug for patients aged 11 and above with eosinophilic esophagitis (EoE). Also, the FDA approved the twice-daily use of EOHILIA 2 mg, based on efficacy and safety data gathered from two 12-week multicenter, randomized, double-blind, parallel group, placebo-controlled studies involving individuals aged 11 to 56 with EoE._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Cell Regeneration Medicine Market?#_x000D_

Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd. _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Cell Regeneration Medicine Market By 2025?#_x000D_

North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_